Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, MARH (UK), MCPS, MRCGP (UK), FRCGP (UK)
Internal Medicine Specialist
MBBS, MARH (UK), MCPS, MRCGP (UK), FRCGP (UK)
General Physician
MBBS, FCPS (Medicine), MRCP (UK)
Gastroenterologist
M.B.B.S, F.C.P.S (Gastroenterology)
Internal Medicine Specialist
FCPS (Medicine), MBBS
Internal Medicine Specialist
M.B.B.S, FCPS, FRCP (UK)
Infectious Disease Specialist
MBBS, M.D (USA), DABIM & ID (USA)
Internal Medicine Specialist
M.B.B.S, FCPS
Gastroenterologist
MBBS, FCPS (Gastroenterology & Hepatology), MRCP (Medicine)
Gastroenterologist
M.B.B.S., F.C.P.S., F.C.P.S.
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures